|
|||||
|
|
Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002 |
|
| Affiliation: | 2. CALGB Statistical Center, Duke University Medical Center, Durham, North Carolina;3. State University of New York Upstate Medical University, Syracuse, New York;4. Medical University of South Carolina, Charleston, South Carolina;5. University of Chicago, Chicago, Illinois |
| Abstract: | |
| Keywords: | Phase II Paclitaxel Topotecan Etoposide Small-cell lung cancer |
| 本文献已被 ScienceDirect 等数据库收录！ | |